The potential roles of type I interferon activated neutrophils and neutrophil extracellular traps (NETs) in the pathogenesis of primary Sjögren’s syndrome

Objective Neutrophils and aberrant NETosis have been implicated in the pathogenesis of diverse autoimmune diseases; however, their roles in primary Sjögren's syndrome (pSS) remain unclear. We aimed to reveal the potential roles of neutrophils and neutrophil extracellular traps (NETs) in pSS. Me...

Full description

Saved in:
Bibliographic Details
Published inArthritis research & therapy Vol. 24; no. 1; pp. 1 - 13
Main Authors Peng, Yu, Wu, Xunyao, Zhang, Shulan, Deng, Chuiwen, Zhao, Lidan, Wang, Mu, Wu, Qingjun, Yang, Huaxia, Zhou, Jiaxin, Peng, Linyi, Luo, Xuan, Chen, Yingying, Wang, Anqi, Xiao, Qiufeng, Zhang, Wen, Zhao, Yan, Zeng, Xiaofeng, Fei, Yunyun
Format Journal Article
LanguageEnglish
Published London BioMed Central Ltd 19.07.2022
BioMed Central
BMC
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Objective Neutrophils and aberrant NETosis have been implicated in the pathogenesis of diverse autoimmune diseases; however, their roles in primary Sjögren's syndrome (pSS) remain unclear. We aimed to reveal the potential roles of neutrophils and neutrophil extracellular traps (NETs) in pSS. Methods pSS patients were enrolled and NETosis markers were measured in plasma and labial glands using ELISA and immunofluorescence. The gene signatures of neutrophils were assessed by RNA-Seq and RT-PCR. Reactive oxygen species (ROS), mitochondrial ROS (MitoSOX) production, and JC-1 were measured by flow cytometry. Results NETosis markers including cell-free DNA (cf-DNA) and myeloperoxidase (MPO) in plasma and labial glands from pSS patients were significantly higher than healthy controls (HCs) and were associated with disease activity. RNA sequencing and RT-qPCR revealed activated type I IFN signaling pathway and higher expression of genes related to type I interferon in pSS neutrophils. Further stimulating with IFN-[alpha] 2a in vitro significantly induced ROS production and JC-1 monomer percentage in pSS neutrophils. Conclusions Our data suggest the involvement of neutrophils and enhanced NETosis in pSS patients. Further mechanism study in vitro revealed that type I IFN activation in pSS neutrophils led to mitochondrial damage and related ROS production which finally result in the generation of NETs. Keywords: Primary Sjögren's syndrome, Neutrophils, Neutrophil extracellular traps, Type I interferon, Mitochondrial damage
AbstractList Abstract Objective Neutrophils and aberrant NETosis have been implicated in the pathogenesis of diverse autoimmune diseases; however, their roles in primary Sjögren’s syndrome (pSS) remain unclear. We aimed to reveal the potential roles of neutrophils and neutrophil extracellular traps (NETs) in pSS. Methods pSS patients were enrolled and NETosis markers were measured in plasma and labial glands using ELISA and immunofluorescence. The gene signatures of neutrophils were assessed by RNA-Seq and RT-PCR. Reactive oxygen species (ROS), mitochondrial ROS (MitoSOX) production, and JC-1 were measured by flow cytometry. Results NETosis markers including cell-free DNA (cf-DNA) and myeloperoxidase (MPO) in plasma and labial glands from pSS patients were significantly higher than healthy controls (HCs) and were associated with disease activity. RNA sequencing and RT-qPCR revealed activated type I IFN signaling pathway and higher expression of genes related to type I interferon in pSS neutrophils. Further stimulating with IFN-α 2a in vitro significantly induced ROS production and JC-1 monomer percentage in pSS neutrophils. Conclusions Our data suggest the involvement of neutrophils and enhanced NETosis in pSS patients. Further mechanism study in vitro revealed that type I IFN activation in pSS neutrophils led to mitochondrial damage and related ROS production which finally result in the generation of NETs.
Neutrophils and aberrant NETosis have been implicated in the pathogenesis of diverse autoimmune diseases; however, their roles in primary Sjögren's syndrome (pSS) remain unclear. We aimed to reveal the potential roles of neutrophils and neutrophil extracellular traps (NETs) in pSS. pSS patients were enrolled and NETosis markers were measured in plasma and labial glands using ELISA and immunofluorescence. The gene signatures of neutrophils were assessed by RNA-Seq and RT-PCR. Reactive oxygen species (ROS), mitochondrial ROS (MitoSOX) production, and JC-1 were measured by flow cytometry. NETosis markers including cell-free DNA (cf-DNA) and myeloperoxidase (MPO) in plasma and labial glands from pSS patients were significantly higher than healthy controls (HCs) and were associated with disease activity. RNA sequencing and RT-qPCR revealed activated type I IFN signaling pathway and higher expression of genes related to type I interferon in pSS neutrophils. Further stimulating with IFN-[alpha] 2a in vitro significantly induced ROS production and JC-1 monomer percentage in pSS neutrophils. Our data suggest the involvement of neutrophils and enhanced NETosis in pSS patients. Further mechanism study in vitro revealed that type I IFN activation in pSS neutrophils led to mitochondrial damage and related ROS production which finally result in the generation of NETs.
Neutrophils and aberrant NETosis have been implicated in the pathogenesis of diverse autoimmune diseases; however, their roles in primary Sjögren's syndrome (pSS) remain unclear. We aimed to reveal the potential roles of neutrophils and neutrophil extracellular traps (NETs) in pSS.OBJECTIVENeutrophils and aberrant NETosis have been implicated in the pathogenesis of diverse autoimmune diseases; however, their roles in primary Sjögren's syndrome (pSS) remain unclear. We aimed to reveal the potential roles of neutrophils and neutrophil extracellular traps (NETs) in pSS.pSS patients were enrolled and NETosis markers were measured in plasma and labial glands using ELISA and immunofluorescence. The gene signatures of neutrophils were assessed by RNA-Seq and RT-PCR. Reactive oxygen species (ROS), mitochondrial ROS (MitoSOX) production, and JC-1 were measured by flow cytometry.METHODSpSS patients were enrolled and NETosis markers were measured in plasma and labial glands using ELISA and immunofluorescence. The gene signatures of neutrophils were assessed by RNA-Seq and RT-PCR. Reactive oxygen species (ROS), mitochondrial ROS (MitoSOX) production, and JC-1 were measured by flow cytometry.NETosis markers including cell-free DNA (cf-DNA) and myeloperoxidase (MPO) in plasma and labial glands from pSS patients were significantly higher than healthy controls (HCs) and were associated with disease activity. RNA sequencing and RT-qPCR revealed activated type I IFN signaling pathway and higher expression of genes related to type I interferon in pSS neutrophils. Further stimulating with IFN-α 2a in vitro significantly induced ROS production and JC-1 monomer percentage in pSS neutrophils.RESULTSNETosis markers including cell-free DNA (cf-DNA) and myeloperoxidase (MPO) in plasma and labial glands from pSS patients were significantly higher than healthy controls (HCs) and were associated with disease activity. RNA sequencing and RT-qPCR revealed activated type I IFN signaling pathway and higher expression of genes related to type I interferon in pSS neutrophils. Further stimulating with IFN-α 2a in vitro significantly induced ROS production and JC-1 monomer percentage in pSS neutrophils.Our data suggest the involvement of neutrophils and enhanced NETosis in pSS patients. Further mechanism study in vitro revealed that type I IFN activation in pSS neutrophils led to mitochondrial damage and related ROS production which finally result in the generation of NETs.CONCLUSIONSOur data suggest the involvement of neutrophils and enhanced NETosis in pSS patients. Further mechanism study in vitro revealed that type I IFN activation in pSS neutrophils led to mitochondrial damage and related ROS production which finally result in the generation of NETs.
Objective Neutrophils and aberrant NETosis have been implicated in the pathogenesis of diverse autoimmune diseases; however, their roles in primary Sjögren's syndrome (pSS) remain unclear. We aimed to reveal the potential roles of neutrophils and neutrophil extracellular traps (NETs) in pSS. Methods pSS patients were enrolled and NETosis markers were measured in plasma and labial glands using ELISA and immunofluorescence. The gene signatures of neutrophils were assessed by RNA-Seq and RT-PCR. Reactive oxygen species (ROS), mitochondrial ROS (MitoSOX) production, and JC-1 were measured by flow cytometry. Results NETosis markers including cell-free DNA (cf-DNA) and myeloperoxidase (MPO) in plasma and labial glands from pSS patients were significantly higher than healthy controls (HCs) and were associated with disease activity. RNA sequencing and RT-qPCR revealed activated type I IFN signaling pathway and higher expression of genes related to type I interferon in pSS neutrophils. Further stimulating with IFN-[alpha] 2a in vitro significantly induced ROS production and JC-1 monomer percentage in pSS neutrophils. Conclusions Our data suggest the involvement of neutrophils and enhanced NETosis in pSS patients. Further mechanism study in vitro revealed that type I IFN activation in pSS neutrophils led to mitochondrial damage and related ROS production which finally result in the generation of NETs. Keywords: Primary Sjögren's syndrome, Neutrophils, Neutrophil extracellular traps, Type I interferon, Mitochondrial damage
Objective Neutrophils and aberrant NETosis have been implicated in the pathogenesis of diverse autoimmune diseases; however, their roles in primary Sjögren’s syndrome (pSS) remain unclear. We aimed to reveal the potential roles of neutrophils and neutrophil extracellular traps (NETs) in pSS. Methods pSS patients were enrolled and NETosis markers were measured in plasma and labial glands using ELISA and immunofluorescence. The gene signatures of neutrophils were assessed by RNA-Seq and RT-PCR. Reactive oxygen species (ROS), mitochondrial ROS (MitoSOX) production, and JC-1 were measured by flow cytometry. Results NETosis markers including cell-free DNA (cf-DNA) and myeloperoxidase (MPO) in plasma and labial glands from pSS patients were significantly higher than healthy controls (HCs) and were associated with disease activity. RNA sequencing and RT-qPCR revealed activated type I IFN signaling pathway and higher expression of genes related to type I interferon in pSS neutrophils. Further stimulating with IFN-α 2a in vitro significantly induced ROS production and JC-1 monomer percentage in pSS neutrophils. Conclusions Our data suggest the involvement of neutrophils and enhanced NETosis in pSS patients. Further mechanism study in vitro revealed that type I IFN activation in pSS neutrophils led to mitochondrial damage and related ROS production which finally result in the generation of NETs.
ArticleNumber 170
Audience Academic
Author Deng, Chuiwen
Peng, Linyi
Wang, Anqi
Wang, Mu
Yang, Huaxia
Chen, Yingying
Fei, Yunyun
Wu, Xunyao
Zhang, Shulan
Zhou, Jiaxin
Luo, Xuan
Peng, Yu
Wu, Qingjun
Xiao, Qiufeng
Zeng, Xiaofeng
Zhang, Wen
Zhao, Yan
Zhao, Lidan
Author_xml – sequence: 1
  givenname: Yu
  surname: Peng
  fullname: Peng, Yu
– sequence: 2
  givenname: Xunyao
  surname: Wu
  fullname: Wu, Xunyao
– sequence: 3
  givenname: Shulan
  surname: Zhang
  fullname: Zhang, Shulan
– sequence: 4
  givenname: Chuiwen
  surname: Deng
  fullname: Deng, Chuiwen
– sequence: 5
  givenname: Lidan
  surname: Zhao
  fullname: Zhao, Lidan
– sequence: 6
  givenname: Mu
  surname: Wang
  fullname: Wang, Mu
– sequence: 7
  givenname: Qingjun
  surname: Wu
  fullname: Wu, Qingjun
– sequence: 8
  givenname: Huaxia
  surname: Yang
  fullname: Yang, Huaxia
– sequence: 9
  givenname: Jiaxin
  surname: Zhou
  fullname: Zhou, Jiaxin
– sequence: 10
  givenname: Linyi
  surname: Peng
  fullname: Peng, Linyi
– sequence: 11
  givenname: Xuan
  surname: Luo
  fullname: Luo, Xuan
– sequence: 12
  givenname: Yingying
  surname: Chen
  fullname: Chen, Yingying
– sequence: 13
  givenname: Anqi
  surname: Wang
  fullname: Wang, Anqi
– sequence: 14
  givenname: Qiufeng
  surname: Xiao
  fullname: Xiao, Qiufeng
– sequence: 15
  givenname: Wen
  surname: Zhang
  fullname: Zhang, Wen
– sequence: 16
  givenname: Yan
  surname: Zhao
  fullname: Zhao, Yan
– sequence: 17
  givenname: Xiaofeng
  surname: Zeng
  fullname: Zeng, Xiaofeng
– sequence: 18
  givenname: Yunyun
  surname: Fei
  fullname: Fei, Yunyun
BookMark eNp9UktuFDEQbaEg8oELsLLEJiw6-Nfd9gYpigKMFMGCsLbc7uoZj3rsxvZEzI5rsOAaXICbcBLcM4PIRAhZlsvlV68-fqfFkfMOiuI5wReEiPpVJAw3VYkpzVvUuOSPihPCG1HWrKZH9-zj4jTGJc5ISfmT4phVouKM0pPi--0C0OgTuGT1gIIfICLfo7QZAc2QdQlCD8E7pE2ydzpBhxysU_Djwg4RaXf_juBLCtrAMKwHHVC2x4jO31_fxpeZCqUpl04LPwcH0W4TjcGudNigj8ufP-YB3K-v3yKKG9cFv4KnxeNeDxGe7c-z4tOb69urd-XNh7ezq8ub0tS4TmXLGpFb01VrGOeCQl9xrAWXuXXdEiEAKJOyrmrCJceU667hVS9FL7uqEZKdFbMdb-f1Uu1LUl5btXX4MFc6JGsGUK02reRCSKIbzrLdklqKVtfU1EwSk7le77jGdbuCzuTJBj0ckB6-OLtQc3-nJJUVrUQmON8TBP95DTGplY3TTLUDv46K1pLihhLMM_TFA-jSr4PLo5pQhHHMcfUXNde5Aet6P33SRKouG4JFQyhmGXXxD1ReHaysycrrbfYfBIhdgAk-xgC9MjbpZP3Ulh0UwWqSqdrJVGXxqa1M1VQ3fRD6Zzz_CfoNryXtDQ
CitedBy_id crossref_primary_10_1016_j_it_2025_01_008
crossref_primary_10_1096_fj_202402514R
crossref_primary_10_3389_fvets_2024_1509399
crossref_primary_10_1093_rheumatology_kead545
crossref_primary_10_1167_iovs_65_4_33
crossref_primary_10_1038_s41598_024_74705_w
crossref_primary_10_3390_diagnostics14030258
crossref_primary_10_3389_fmicb_2023_1126896
crossref_primary_10_1016_j_biopha_2024_116885
crossref_primary_10_1136_rmdopen_2023_003559
crossref_primary_10_2147_IJGM_S504780
crossref_primary_10_3389_fimmu_2024_1421436
crossref_primary_10_1016_j_jtos_2023_09_012
crossref_primary_10_1016_j_cytogfr_2024_12_001
crossref_primary_10_1016_j_jdermsci_2024_05_002
crossref_primary_10_1097_BOR_0000000000000986
crossref_primary_10_1016_j_jep_2025_119391
crossref_primary_10_1111_exd_14913
crossref_primary_10_1016_j_jtauto_2025_100280
crossref_primary_10_3389_fimmu_2024_1408880
crossref_primary_10_1016_j_jhazmat_2023_131236
crossref_primary_10_1186_s12943_025_02249_2
crossref_primary_10_1016_j_jare_2024_03_015
crossref_primary_10_1016_j_bioactmat_2024_01_020
crossref_primary_10_3389_fimmu_2023_1207545
crossref_primary_10_1007_s12026_024_09453_0
crossref_primary_10_1016_j_heliyon_2024_e41342
crossref_primary_10_2147_JIR_S433110
crossref_primary_10_1007_s11926_023_01125_6
crossref_primary_10_1016_j_clim_2024_110334
crossref_primary_10_1016_j_heliyon_2024_e40577
crossref_primary_10_18596_jotcsa_1404431
crossref_primary_10_1016_j_jtos_2024_02_003
crossref_primary_10_1111_imm_13829
crossref_primary_10_1016_j_jaut_2024_103296
crossref_primary_10_1007_s11418_023_01702_0
crossref_primary_10_3389_fimmu_2023_1181761
crossref_primary_10_3389_fddsv_2024_1404103
crossref_primary_10_3899_jrheum_2022_0827
crossref_primary_10_1111_1756_185X_15350
Cites_doi 10.1002/art.39818
10.1038/nm.4027
10.1016/j.tripleo.2008.09.015
10.1073/pnas.87.11.4115
10.1007/s00281-013-0375-7
10.1002/art.1780291105
10.1016/j.jaci.2017.10.030
10.1590/abd1806-4841.20175476
10.1002/art.39296
10.1093/rheumatology/kev217
10.1126/sciimmunol.aag3358
10.4049/jimmunol.1202388
10.1093/rheumatology/keaa016
10.1038/s41598-020-76701-2
10.1016/j.celrep.2014.06.044
10.1126/science.1092385
10.1038/nm.1959
10.1126/scitranslmed.3001180
10.1038/s41467-020-19412-6
10.1136/annrheumdis-2018-213746
10.1016/j.bbrc.2018.04.234
10.1038/s41467-019-09160-7
10.1111/jcmm.15321
10.4049/jimmunol.1100450
10.4330/wjc.v7.i12.829
10.1126/scitranslmed.3005580
10.1136/ard.61.6.554
10.1136/rmdopen-2014-000022
10.1038/s41420-021-00491-3
10.1016/S0167-5699(97)01087-6
10.1016/j.mito.2018.01.007
10.1136/annrheumdis-2019-216588
10.4049/jimmunol.0902199
10.1038/s41584-018-0039-z
10.1016/j.jaut.2019.01.003
10.4049/jimmunol.1100123
10.1084/jem.20100239
10.1038/nrrheum.2011.132
10.1016/S0140-6736(05)66990-5
10.1172/jci.insight.134189
ContentType Journal Article
Copyright COPYRIGHT 2022 BioMed Central Ltd.
2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2022. The Author(s).
The Author(s) 2022
Copyright_xml – notice: COPYRIGHT 2022 BioMed Central Ltd.
– notice: 2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2022. The Author(s).
– notice: The Author(s) 2022
DBID AAYXX
CITATION
3V.
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/s13075-022-02860-4
DatabaseName CrossRef
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
Directory of Open Access Journals
DatabaseTitle CrossRef
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList

MEDLINE - Academic

Publicly Available Content Database
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1478-6362
EndPage 13
ExternalDocumentID oai_doaj_org_article_bacb948891a743cb9b1698ba62c6391c
PMC9295258
A710871203
10_1186_s13075_022_02860_4
GeographicLocations China
GeographicLocations_xml – name: China
GrantInformation_xml – fundername: ;
  grantid: 81971544; 82172343; 81971545
– fundername: ;
  grantid: pumch201911238
– fundername: ;
  grantid: 2020-I2M-C & T-A-002
GroupedDBID ---
.GJ
0R~
23N
2WC
4.4
5GY
5VS
6J9
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAYXX
ABUWG
ACGFS
ACJQM
ADBBV
ADUKV
AEGXH
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIAM
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CITATION
CS3
DIK
E3Z
EBD
EBLON
EMOBN
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
HZ~
INH
INR
ITC
KQ8
M1P
O5R
O5S
O9-
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
ROL
RPM
RSV
SMD
SOJ
SV3
TR2
U2A
UKHRP
WOQ
PMFND
3V.
7XB
8FK
AZQEC
DWQXO
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
PRINS
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c606t-b378229a5bc34482ef540a849362ab188ee23996561494024ad745f98f9d57893
IEDL.DBID DOA
ISSN 1478-6362
1478-6354
IngestDate Wed Aug 27 01:29:43 EDT 2025
Thu Aug 21 18:42:11 EDT 2025
Fri Jul 11 01:53:44 EDT 2025
Fri Jul 25 22:53:26 EDT 2025
Tue Jun 17 21:30:11 EDT 2025
Tue Jun 10 20:19:48 EDT 2025
Tue Jul 01 04:00:59 EDT 2025
Thu Apr 24 23:08:22 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c606t-b378229a5bc34482ef540a849362ab188ee23996561494024ad745f98f9d57893
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://doaj.org/article/bacb948891a743cb9b1698ba62c6391c
PMID 35854322
PQID 2691340405
PQPubID 42876
PageCount 13
ParticipantIDs doaj_primary_oai_doaj_org_article_bacb948891a743cb9b1698ba62c6391c
pubmedcentral_primary_oai_pubmedcentral_nih_gov_9295258
proquest_miscellaneous_2692072104
proquest_journals_2691340405
gale_infotracmisc_A710871203
gale_infotracacademiconefile_A710871203
crossref_citationtrail_10_1186_s13075_022_02860_4
crossref_primary_10_1186_s13075_022_02860_4
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2022-07-19
PublicationDateYYYYMMDD 2022-07-19
PublicationDate_xml – month: 07
  year: 2022
  text: 2022-07-19
  day: 19
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
PublicationTitle Arthritis research & therapy
PublicationYear 2022
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References F Su (2860_CR7) 2017; 92
D Azzouz (2860_CR17) 2021; 7
C Carmona-Rivera (2860_CR18) 2013; 35
RJ Falk (2860_CR8) 1990; 87
AN Rao (2860_CR41) 2015; 7
E Rivière (2860_CR31) 2020; 79
RI Fox (2860_CR13) 2005; 366
L Zheng (2860_CR16) 2009; 107
R Khandpur (2860_CR2) 2013; 5
K Kessenbrock (2860_CR23) 2009; 15
W Jin (2860_CR38) 2018; 501
Y Lu (2860_CR39) 2020; 24
P Mistry (2860_CR33) 2018; 77
C Vitali (2860_CR14) 2002; 61
F Apel (2860_CR4) 2018; 14
SW Edwards (2860_CR10) 1997; 18
P Li (2860_CR11) 2010; 207
2860_CR12
R Seror (2860_CR15) 2015; 1
2860_CR34
H Wang (2860_CR25) 2015; 67
Y Furumoto (2860_CR27) 2017; 69
C Lood (2860_CR37) 2016; 22
L Moreira-Teixeira (2860_CR28) 2020; 11
P López (2860_CR19) 2020; 59
N Marketos (2860_CR29) 2019; 37 Suppl 118(3)
V Brinkmann (2860_CR6) 2004; 303
J Perdomo (2860_CR40) 2019; 10
AM Lin (2860_CR35) 2011; 187
E Gul (2860_CR20) 2018; 142
E Villanueva (2860_CR1) 2011; 187
KD Metzler (2860_CR5) 2014; 8
Y Peng (2860_CR30) 2020; 10
E Hacbarth (2860_CR32) 1986; 29
MF Denny (2860_CR36) 2010; 184
MJ Kaplan (2860_CR22) 2011; 7
D Söderberg (2860_CR3) 2015; 54
R Lande (2860_CR9) 2011; 3
M Ribon (2860_CR24) 2019; 98
K Małota (2860_CR21) 2019; 44
JM Kahlenberg (2860_CR26) 2013; 190
References_xml – volume: 69
  start-page: 148
  issue: 1
  year: 2017
  ident: 2860_CR27
  publication-title: Arthritis Rheum
  doi: 10.1002/art.39818
– volume: 22
  start-page: 146
  issue: 2
  year: 2016
  ident: 2860_CR37
  publication-title: Nat Med
  doi: 10.1038/nm.4027
– volume: 107
  start-page: e12
  issue: 1
  year: 2009
  ident: 2860_CR16
  publication-title: Oral Surg Oral Med Oral Pathol Oral Radiol Endod
  doi: 10.1016/j.tripleo.2008.09.015
– volume: 87
  start-page: 4115
  issue: 11
  year: 1990
  ident: 2860_CR8
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.87.11.4115
– volume: 35
  start-page: 455
  issue: 4
  year: 2013
  ident: 2860_CR18
  publication-title: Semin Immunopathol
  doi: 10.1007/s00281-013-0375-7
– volume: 37 Suppl 118(3)
  start-page: 185
  year: 2019
  ident: 2860_CR29
  publication-title: Clin Exp Rheumatol
– volume: 29
  start-page: 1334
  issue: 11
  year: 1986
  ident: 2860_CR32
  publication-title: Arthritis Rheum
  doi: 10.1002/art.1780291105
– volume: 142
  start-page: 246
  issue: 1
  year: 2018
  ident: 2860_CR20
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2017.10.030
– volume: 92
  start-page: 466
  issue: 4
  year: 2017
  ident: 2860_CR7
  publication-title: An Bras Dermatol
  doi: 10.1590/abd1806-4841.20175476
– volume: 67
  start-page: 3190
  issue: 12
  year: 2015
  ident: 2860_CR25
  publication-title: Arthritis Rheum
  doi: 10.1002/art.39296
– volume: 54
  start-page: 2085
  issue: 11
  year: 2015
  ident: 2860_CR3
  publication-title: Rheumatology (Oxford)
  doi: 10.1093/rheumatology/kev217
– ident: 2860_CR12
  doi: 10.1126/sciimmunol.aag3358
– volume: 190
  start-page: 1217
  issue: 3
  year: 2013
  ident: 2860_CR26
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1202388
– volume: 59
  start-page: 1752
  issue: 7
  year: 2020
  ident: 2860_CR19
  publication-title: Rheumatology (Oxford)
  doi: 10.1093/rheumatology/keaa016
– volume: 10
  start-page: 19629
  issue: 1
  year: 2020
  ident: 2860_CR30
  publication-title: Sci Rep
  doi: 10.1038/s41598-020-76701-2
– volume: 8
  start-page: 883
  issue: 3
  year: 2014
  ident: 2860_CR5
  publication-title: Cell Rep
  doi: 10.1016/j.celrep.2014.06.044
– volume: 303
  start-page: 1532
  issue: 5663
  year: 2004
  ident: 2860_CR6
  publication-title: Science
  doi: 10.1126/science.1092385
– volume: 15
  start-page: 623
  issue: 6
  year: 2009
  ident: 2860_CR23
  publication-title: Nat Med
  doi: 10.1038/nm.1959
– volume: 3
  start-page: 73ra19
  issue: 73
  year: 2011
  ident: 2860_CR9
  publication-title: Sci Transl Med
  doi: 10.1126/scitranslmed.3001180
– volume: 11
  start-page: 5566
  issue: 1
  year: 2020
  ident: 2860_CR28
  publication-title: Nat Commun
  doi: 10.1038/s41467-020-19412-6
– volume: 77
  start-page: 1825
  issue: 12
  year: 2018
  ident: 2860_CR33
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2018-213746
– volume: 501
  start-page: 273
  issue: 1
  year: 2018
  ident: 2860_CR38
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2018.04.234
– volume: 10
  start-page: 1322
  issue: 1
  year: 2019
  ident: 2860_CR40
  publication-title: Nat Commun
  doi: 10.1038/s41467-019-09160-7
– volume: 24
  start-page: 6690
  issue: 12
  year: 2020
  ident: 2860_CR39
  publication-title: J Cell Mol Med
  doi: 10.1111/jcmm.15321
– volume: 187
  start-page: 538
  issue: 1
  year: 2011
  ident: 2860_CR1
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1100450
– volume: 7
  start-page: 829
  issue: 12
  year: 2015
  ident: 2860_CR41
  publication-title: World J Cardiol
  doi: 10.4330/wjc.v7.i12.829
– volume: 5
  start-page: 178ra140
  issue: 178
  year: 2013
  ident: 2860_CR2
  publication-title: Sci Transl Med
  doi: 10.1126/scitranslmed.3005580
– volume: 61
  start-page: 554
  issue: 6
  year: 2002
  ident: 2860_CR14
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.61.6.554
– volume: 1
  issue: 1
  year: 2015
  ident: 2860_CR15
  publication-title: RMD Open
  doi: 10.1136/rmdopen-2014-000022
– volume: 7
  start-page: 113
  issue: 1
  year: 2021
  ident: 2860_CR17
  publication-title: Cell Death Dis
  doi: 10.1038/s41420-021-00491-3
– volume: 18
  start-page: 320
  issue: 7
  year: 1997
  ident: 2860_CR10
  publication-title: Immunol Today
  doi: 10.1016/S0167-5699(97)01087-6
– volume: 44
  start-page: 111
  year: 2019
  ident: 2860_CR21
  publication-title: Mitochondrion
  doi: 10.1016/j.mito.2018.01.007
– volume: 79
  start-page: 1468
  issue: 11
  year: 2020
  ident: 2860_CR31
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2019-216588
– volume: 184
  start-page: 3284
  issue: 6
  year: 2010
  ident: 2860_CR36
  publication-title: J Immunol
  doi: 10.4049/jimmunol.0902199
– volume: 14
  start-page: 467
  issue: 8
  year: 2018
  ident: 2860_CR4
  publication-title: Nat Rev Rheumatol
  doi: 10.1038/s41584-018-0039-z
– volume: 98
  start-page: 122
  year: 2019
  ident: 2860_CR24
  publication-title: J Autoimmun
  doi: 10.1016/j.jaut.2019.01.003
– volume: 187
  start-page: 490
  issue: 1
  year: 2011
  ident: 2860_CR35
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1100123
– volume: 207
  start-page: 1853
  issue: 9
  year: 2010
  ident: 2860_CR11
  publication-title: J Exp Med
  doi: 10.1084/jem.20100239
– volume: 7
  start-page: 691
  issue: 12
  year: 2011
  ident: 2860_CR22
  publication-title: Nat Rev Rheumatol
  doi: 10.1038/nrrheum.2011.132
– volume: 366
  start-page: 321
  issue: 9482
  year: 2005
  ident: 2860_CR13
  publication-title: Lancet
  doi: 10.1016/S0140-6736(05)66990-5
– ident: 2860_CR34
  doi: 10.1172/jci.insight.134189
SSID ssj0022924
Score 2.545966
Snippet Objective Neutrophils and aberrant NETosis have been implicated in the pathogenesis of diverse autoimmune diseases; however, their roles in primary Sjögren's...
Neutrophils and aberrant NETosis have been implicated in the pathogenesis of diverse autoimmune diseases; however, their roles in primary Sjögren's syndrome...
Objective Neutrophils and aberrant NETosis have been implicated in the pathogenesis of diverse autoimmune diseases; however, their roles in primary Sjögren’s...
Abstract Objective Neutrophils and aberrant NETosis have been implicated in the pathogenesis of diverse autoimmune diseases; however, their roles in primary...
SourceID doaj
pubmedcentral
proquest
gale
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Enrichment Source
Index Database
StartPage 1
SubjectTerms Analysis
Antibodies
Arthritis
Autoimmune diseases
Biological response modifiers
Care and treatment
Cell culture
Diagnosis
Disease
Flow cytometry
Gene expression
Granulocytes
Health aspects
Hospitals
Interferon
Medical research
Mitochondrial damage
Neutrophil extracellular traps
Neutrophils
Pathogenesis
Pathogens
Plasma
Primary Sjögren’s syndrome
Reactive oxygen species
Sjogren's syndrome
Type I interferon
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NbtQwELagSIgL4lcsFGQkJEDIan7sxD6hgloVpPZCK-3Nsh2n3apKQpLlzGtw4DV4Ad6EJ2HG6902IPWwUnY9jtea8fgbe34IeSUqLBYtE1ZzKxm3zjElKs9MqYxzFiBqjbHDh0fFwQn_PBfzeOA2RLfKtU4MirpqHZ6R72QF3hGDyIn33VeGVaPwdjWW0LhJbmHqMpTqcn5pcGVqVdSWg6UEGytfB83IYmcA3V1ibHIGH1kkjE82ppC__38t_a_n5JWtaP8euRsxJN1dMf0-ueGbB-T2Ybwlf0h-Au9p147oCAR06EA40LameNxKP1HMENHXvm8bilEN3wBtVrTxy7Fvu7PFxUBNc_U7BfXdGzzgR49VCs_dQN8c7R0Pb-FVdMSxAEa2p6g1F2GgbpXCgn45__0L7Pnmz_cfA13nRnhETvb3jj8esFiGgTmwbkZmc0QRygjrcjDmMl8DyjOSK9j7jE2l9B4DZAvMKarAHOWmKrmolaxVBfpA5Y_JVtM2_gmhwsokN6m1oqy4k7kpstIlVlRVYQQv-Yykax5oF3OUY6mMCx1sFVnoFd808E0Hvmno827TJ07vWuoPyNoNJWbXDj-0_amOixUAhLMKNJtKDQAseLZpoaSFf-sA0KVuRl6jYGjUAcgBE0MZYJKYTUvvAmwDQzRL8hnZnlDC2nXT5rVo6ag7Bn0p6TPyctOMPdEfrvHtMtBkmNkugQmVE5GczGza0izOQv5wQMQiE_Lp9YM_I3eysDxKlqptsjX2S_8cANhoX4RV9hcy1zCS
  priority: 102
  providerName: ProQuest
Title The potential roles of type I interferon activated neutrophils and neutrophil extracellular traps (NETs) in the pathogenesis of primary Sjögren’s syndrome
URI https://www.proquest.com/docview/2691340405
https://www.proquest.com/docview/2692072104
https://pubmed.ncbi.nlm.nih.gov/PMC9295258
https://doaj.org/article/bacb948891a743cb9b1698ba62c6391c
Volume 24
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3ditNAFB50BfFG_MXqWkYQVCRsfmYyM5dd6bIKW0S30LthZjLZrSxJSVKvfQ0vfA1fwDfxSTwnP6VR0BsvWtLOmaST85-e8w0hz3mGm0XLMMiZlQGzzgWKZz4wQhnnLISoOfYOny3S0yV7t-Krva2-sCasgwfubtyRNc4qkDIVGXB2cGyjVElr0tiBc40cWl_weUMy1adaMaQVQ4uMTI9qsNQCO5FjeMk0DNjIDbVo_X_a5N_rJPccz8kdcruPGOms-6V3yTVf3CM3z_r_xO-Tb8BpuikbLPsBOiwXrGmZU3y4St9SxIOocl-VBcUehs8QW2a08NumKjeX66uammL_MwVjXRl8nI_1qRSONzV9uZif16_gVLTBa0HQWF6gjVy3F9p0gBX046cf3yF7L35--VrTAQnhAVmezM_fnAb9pguBg1ymCWyCMYMy3LoEUrfY5xDTGckUeDpjIym9x3bYFBFEFSSfzGSC8VzJXGWg_Sp5SA6KsvCPCOVWhomJrOUiY04mwDPhQsuzLDWcCTYh0cAD7XpEctwY40q3mYlMdcc3DXzTLd80zHm9m9Mv76_Ux8jaHSViabdfgITpXsL0vyRsQl6gYGjUeOSA6RsXYJGInaVnEKRB2hmHyYQcjihBU914eBAt3VuKWscp1j6AKeUT8mw3jDOx-q3w5baliRHHLoQFiZFIjlY2HinWly1aOMS_POby8f-4FU_IrbhVIhFE6pAcNNXWP4WgrLFTcl2sxJTcOJ4v3n-YttoI78t49guSCDrO
linkProvider Directory of Open Access Journals
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtQwELaqIgEXxK_YUsBIIEAoapK1E_uAUIFWu7S7F7bS3oztONtFVbIkWRA3XoMDr8CRF-BNeBJmssm2Aam3HiIlaztea8Yz38TzQ8hjnmCxaOF7KTPCY8ZaT_LEeTqW2loDEDXF2OHROBocsXdTPt0gP9tYGHSrbGViLaiT3OI38p0wwjNiYDn-avHJw6pReLraltBYscWB-_oFTLby5fAt0PdJGO7vTd4MvKaqgGcBrFee6aNSlJob2wfbJHQpgBYtmARRrk0ghHMY7xlhikwJ1hXTScx4KkUqE2BvTL4EIv8SKF4fjb14emrghXJVRJeBZQaKnLVBOiLaKUFXxBgLHcIlIt9jHUVY1wv4Xyv866l5RvXtXyfXGsxKd1dMdoNsuOwmuTxqTuVvkR_Aa3SRV-h4BP3QYbGkeUrx8y4dUsxIUaSuyDOKURSfAd0mNHPLqsgXx_OTkurs7DMFdVFoPFBAD1kK94uSPhvvTcrn8Cpa4VwAW_MZSul5PdFilTKDvv_4-9escNmfb99L2uZiuE2OLoRAd8hmlmfuLqHcCL-vA2N4nDAr-joKY-sbniSR5ixmPRK0NFC2yYmOpTlOVG0biUit6KaAbqqmm4IxL9ZjmuWd2_s1knbdE7N51z_kxUw1wgEAizUSJKkMNAA6uDdBJIWBf2sBQAa2R54iYyiUOUgB3YROwCIxe5faBZgIhm_o93tku9MTZIXtNrespRpZVarTndUjj9bNOBL97zKXL-s-IWbS82FBcYclOyvrtmTz4zpfOSBwHnKxdf7kD8mVwWR0qA6H44N75GpYb5XYC-Q22ayKpbsP4K8yD-odR8mHi97ifwEPqWqH
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+potential+roles+of+type+I+interferon+activated+neutrophils+and+neutrophil+extracellular+traps+in+the+pathogenesis+of+primary+Sj%C3%B6gren%27s+syndrome&rft.jtitle=Arthritis+research+%26+therapy&rft.au=Peng%2C+Yu&rft.au=Wu%2C+Xunyao&rft.au=Zhang%2C+Shulan&rft.au=Deng%2C+Chuiwen&rft.date=2022-07-19&rft.pub=BioMed+Central+Ltd&rft.issn=1478-6354&rft.volume=24&rft.issue=1&rft_id=info:doi/10.1186%2Fs13075-022-02860-4&rft.externalDocID=A710871203
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1478-6362&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1478-6362&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1478-6362&client=summon